Review of Melanoma Antigens Recognized by Monoclonal Antibodies (MAbs). Their Functional Significance and Applications in Diagnosis and Treatment of Melanoma

References

• Carey G E, Takahashi T, Resnick L A, et al. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 1976; 73: 3278–82
   PubMed Web of Science ®Google Scholar
• Shiku H, Takahashi T, Oettgen H F, Old L. J. Cell surface antigens of human malignant melanoma. II Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med 1976; 144: 873–81
   Google Scholar
• Shiku H, Takahashi T, Resnick L A, et al. Cell surface antigens of human malignant melanoma. III Recognition of autoantibodies with unusual characteristics. J Exp Med 1977; 145: 784–9
   Google Scholar
• Lewis M G, Ikonopisov R L, Nairn R C, et al. Tumour specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J 1969; 3: 547–52
   PubMed Web of Science ®Google Scholar
• Lewis M. G. Immunology of human malignant melanoma. Ser Haematol 1972; 5: 44–65
   PubMedGoogle Scholar
• Bodurtha A J, Chee D O, Lauciuse J F, et al. Clinical and immunological significance of human melanoma cytotoxic antibody. Cancer Res 1975; 35: 189–93
   PubMed Web of Science ®Google Scholar
• Morton D L, Malmgren R A, Holmes E C, Ketcham A. S. Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 1968; 64: 233–40
   PubMed Web of Science ®Google Scholar
• Mersey P, Honeyman M, Edwards A, et al. Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera. Int J Cancer 1976; 18: 564–73
   Google Scholar
• Irie R F, Irie K, Morton D. C. A membrane antigen common to human cancer and fetal brain tissues. Cancer Res 1976; 36: 3510–7
   PubMed Web of Science ®Google Scholar
• Irie R F, Giuliano A E, Golub S H, Morton D. L. Oncofetal antigens: a tumor associated fetal antigen immunogenic in man. J Natl Cancer Inst 1979; 63: 367–73
   Google Scholar
• Irie R F, Sze L L, Saxton R. E. Human antibody to OFA-1 a tumor antigen, produced in vitro by Epstein-Barr virus—transformed human B-lymphoid cell lines. Proc Natl Acad Sci USA 1982; 79: 5666–70
   PubMed Web of Science ®Google Scholar
• Tai T, Paulson J C, Cahan C D, Irie R. F. Ganglioside GM2 as a human tumor antigen (OFA-1–1). Proc Natl Acad Sci USA 1983; 80: 5392–6
   PubMed Web of Science ®Google Scholar
• Cahan C D, Irie R F, Singh R, Cassidenti A, Paulson J. C. Identification of a human neuroectodermal tumor antigen (OFA-1–2) as ganglioside GD2. Proc Natl Acad Sci USA 1982; 79: 7629–33
   PubMed Web of Science ®Google Scholar
• Watanabe T, Pukel C S, Takeyama H, et al. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med 1982; 156: 1884–9
   PubMed Web of Science ®Google Scholar
• Hersey P, Edwards A, Murray E, et al. Prognostic significance of leukocyte dependent antibody activity in melanoma patients. J Natl Cancer Inst 1983; 71: 45–53
   Google Scholar
• Preddie E, Hartmann D, Lewis M. G. Human tumor specific antigens (1) An allogeneic antigen from patient “PY” melanoma tumor cell plasma membranes. Cancer Biochem Biophys 1978; 2: 161–7
   Google Scholar
• Hersey P, Murray E, Werkmeister J, McCarthy W. H. Detection of a low molecular weight antigen on melanoma cells by a human antiserum in leucocyte dependent antibody assays. Br J Cancer 1979; 40: 615–27
   Google Scholar
• Preddie E, Hartmann D, Persad S, et al. Isolation of an autologous tumor-specific antigen from tumor cell plasma membranes of a human melanoma patient. Cancer Biochem Biophys 1978; 2: 199–202
   Google Scholar
• Real F X, Mattes J M, Houghton A N, et al. Unique (class 1) tumor antigen of a human melanoma. Serological and biochemical studies. Am Assoc Cancer Res (Abstract) 1983; 923: 233
   Google Scholar
• Houghton A N, Brooks H, Cote R J, et al. Detection of cell surface and intracellular antigens by human monoclonal antibodies. J Exp Med 1983; 158: 53–65
   PubMed Web of Science ®Google Scholar
• Liao S K, Clarke B J, Khosravi M, et al. Human melanoma-specific oncofetal antigen defined by a mouse monoclonal antibody. Int J Cancer 1982; 30: 573–80
   Google Scholar
• Herlyn M, Steplewski Z, Herlyn D, et al. Production and characterization of monoclonal antibodies against human malignant melanoma. Cancer Invest 1983; 1: 215–24
   PubMed Web of Science ®Google Scholar
• Yeh M Y, Hellstrom I, Brown J P, et al. Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci 1979; 76: 2927–31
   PubMed Web of Science ®Google Scholar
• Johnson J P, Demmer-Dieckmann M, Meo T, et al. Surface antigens of human melanoma cells defined by monoclonal antibodies. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse origin. Eur J Immunol 1981; 11: 825–31
   Google Scholar
• Pukel C S, Lloyd K O, Travassos L R, et al. GD3, a prominent ganglioside of human melanoma. J Exp Med 1982; 155: 1133–47
   PubMed Web of Science ®Google Scholar
• Yeh M Y, Hellstrom I, Abe K, et al. A cell surface antigen which is present in the ganglioside fraction and shared by human melanomas. Int J Cancer 1982; 29: 269–75
   Google Scholar
• Nudelman E, Hakomori S, Kannagi R, et al. Characterization of a human melanoma associated ganglioside antigen defined by a monoclonal antibody 4.2. J Biol Chem 1982; 257: 12752–6
   PubMed Web of Science ®Google Scholar
• Bretscher M S, Raff M. C. Mammalian plasma membranes. Nature 1975; 258: 43–9
   PubMed Web of Science ®Google Scholar
• Portoukalian J, Swingelstein G, Dore J. F. Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur J Biochem 1979; 94: 19–23
   PubMedGoogle Scholar
• Hakomori S. Tumor associated glycolipid antigens defined by monoclonal antibodies. Bull Cancer (Paris) 1983; 70: 117–26
   Google Scholar
• Tamir H, Brunner W, Casper D, Rapport M. M. Enhancement by gangliosides of the binding of serotonin to serotonin binding protein. J Neurochem 1980; 34: 1719–24
   Google Scholar
• Dippold W G, Knuth A, Meyer Zum Buschenselde K. H. Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3—ganglioside antibody. Cancer Res 1984; 44(2)806–10
   Google Scholar
• Cheresh D A, Harper J A, Varki N M, Sundsmo J. S. A monoclonal antibody detects an acidic ganglioside on tumor cells and in sera of melanoma patients. Proc Am Assoc Cancer Res 1983; 23: 955
   Google Scholar
• Bumol T F, Reisfeld R. A. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci USA 1982; 79: 1245–9
   PubMed Web of Science ®Google Scholar
• Wilson B S, Giovanna R, Ferrone S. Immunochemical characterization of a human high molecular weight—melanoma associated antigen identified with monoclonal antibodies. Cancer Immunol Immunother 1983; 14: 196–201
   Google Scholar
• Hellstrom I, Garrigues J H, Cabasco L, et al. Studies of a high molecular weight human melanoma associated antigen. J Immunol 1983; 130: 1467–72
   PubMed Web of Science ®Google Scholar
• Ross A H, Cossu G, Herlyn M, et al. Isolation and chemical characterization of a melanoma associated proteoglycan antigen. Arch Biochem Biophys 1983; 225: 370–83
   Google Scholar
• Glimelius B, Norling B, Westermark B, Wasteson A. Composition and distribution of glycosaminoglycans in cultures of human normal and malignant glial cells. Biochem J 1978; 172: 443–56
   Google Scholar
• Hedman K, Johansson S, Vartio T, et al. Structure of the pericellular matrix: association of heparin and chondroitin sulfates with fibronectin-procollagen fibers. Cell 1982; 28: 663–71
   PubMed Web of Science ®Google Scholar
• Stuhlmiller G M, Borowitz M J, Croker B P, Seigler H. F. Multiple assay characterization of murine monoclonal antimelanoma antibodies. Hybridoma 1982; 1: 447–60
   PubMed Web of Science ®Google Scholar
• Bumol T F, Wang Q C, Reisfeld R A, Kaplan N. O. Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth. Proc Natl Acad Sci USA 1983; 80: 529–33
   PubMed Web of Science ®Google Scholar
• Schulz G, Bumol T F, Reisfeld R. A. Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo. Proc Natl Acad Sci USA 1983; 80: 5407–11
   PubMed Web of Science ®Google Scholar
• Hwang K M, Morgan A C, Woodhouse C S, et al. The serotherapy of xenografted human malignant melanoma by a monoclonal antibody (MoAb) to melanoma associated antigen. International Congress of Immunology. 1983, 504–26, Abstract
   Google Scholar
• Nakanishi T, Imai K, Matsui M, et al. The in vivo effects of conjugates of monoclonal antibody with cytotoxic agent on the human melanoma growth in nude mice. 5th International Congress of Immunology. 1983, 504–24, Abstract
   Google Scholar
• Oldham R K, Foon K A, Morgan A C, et al. Monoclonal antibody therapy of malignant melanomas: in vivo localization in cutaneous metastasis after intravenous administration. J Clin Oncol 1984, In press
   Google Scholar
• Ferrone S, Giacomini P, Natali P G, et al. A human high molecular weight—melanoma associated antigen (MHW-MAP) defined by monoclonal antibodies: A useful marker to radioimage tumor lesions in patients with melanoma. Proceedings of First International Symposium on Neutron Capture Therapy, In press
   Google Scholar
• Giacomini P, Ng A K, Kantor R RS, Natali P G, Ferrone S. Double determinant immunoassay to measure a human high-molecular-weight-melanoma-associated antigen. Cancer Res 1983; 43: 3586–90
   Google Scholar
• Giacomini P, Veglia F, Cordiali Fei P, et al. Level of a membrane-bound high molecular weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma. Cancer Res 1984; 44: 1281–7
   PubMed Web of Science ®Google Scholar
• Koprowski H, Steplewski Z, Morgan A C, McIntyre R. F. Monoclonal antibodies to human melanoma-associated antigens: An amplified enzyme-linked immunosorbent assay for detection of antigen, antibody and immune complexes. Cancer Res 1983; 43: 3155–9
   Google Scholar
• Koprowski H, Steplewski Z, Herlyn D, Herlyn M. Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 1978; 75: 3405–9
   PubMed Web of Science ®Google Scholar
• Steplewski Z, Herlyn M, Herlyn D, et al. Reactivity of monoclonal anti-melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Eur J Immunol 1979; 9: 94–6
   PubMed Web of Science ®Google Scholar
• Herlyn M, Clark W H, Mastrangelo M J, et al. Specific immunoreactivity of monoclonal anti-melanoma antibodies. Cancer Res 1980; 40: 717–21
   PubMed Web of Science ®Google Scholar
• Mitchell K F, Fuhrer J P, Steplewski Z, Koprowski H. Structural characterization of the melanoma specific antigen detected by monoclonal antibody 69115Nu-4-B. Mol Immunol 1981; 18: 207–18
   PubMed Web of Science ®Google Scholar
• Steplewski Z, Chang T H, Herlyn M, Koprowski H. Release of monoclonal antibody defined antigens by human colorectal carcinoma and melanoma cells. Cancer Res 1981; 41: 2723–7
   PubMed Web of Science ®Google Scholar
• Carrel S, Accolla R S, Carmagnola A L, Mach J. P. Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res 1980; 40: 2523–8
   PubMed Web of Science ®Google Scholar
• Carrel S, Mach J P, Accolla R. S. Human melanoma-associated antigens detected by monoclonal antibodies. Br J Cancer 1981; 43: 561
   Google Scholar
• Libert A, Ghanem G, Arnould R, et al. Monoclonal antibodies to human melanoma-associated antigens: Study of their specificity and visualization at the cellular level of the antigenic distribution. Anticancer Res 1983; 3: 219–26
   Google Scholar
• Liao S K, Clarke B J, Kwong P C, et al. Common neuroectodermal antigens on human melanomas, neuroblastoma retinoblastoma glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells. Eur J Immunol 1981; 11: 450–4
   Google Scholar
• Seeger R C, Rosenblatt H M, Imai K, Ferrone S. Common antigenic determinants on human melanoma, glioma, neuroblastoma and sarcoma cells defined with monoclonal antibodies. Cancer Res 1981; 41: 2714–7
   Google Scholar
• Houghton A N, Eisinger M, Albino A P, et al. Surface antigens of melanocytes and melanomas. J Exp Med 1982; 156: 1755–66
   PubMed Web of Science ®Google Scholar
• Woodbury R G, Brown J P, Yeh M Y, et al. Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci USA 1980; 77: 2183–7
   PubMed Web of Science ®Google Scholar
• Brown J P, Woodbury R G, Hart C E, et al. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci USA 1981; 78: 534–43
   Google Scholar
• Brown J P, Nishiyama K, Hellstrom I, Hellstrom K. E. Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. J Immunol 1981; 127: 539–46
   PubMed Web of Science ®Google Scholar
• Brown J P, Hewick R M, Hellstrom I, et al. Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature 1982; 296: 171–3
   PubMed Web of Science ®Google Scholar
• Plowman G D, Brown J P, Enns C A, et al. Assignment of the gene for human melanoma-associated antigen p97 to chromosome 3. Nature 1983; 303: 70–2
   PubMed Web of Science ®Google Scholar
• Hellstrom I, Brown T P, Hellstrom K. E. Melanoma-associated antigen p97 continues to be expressed after prolonged exposure of cells to specific antibody. Int J Cancer 1983; 31: 553–5
   Google Scholar
• Larson S M, Carrasquille T A, Krohn K. A. Localization of 131I labelled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 1983; 72: 2101–14
   PubMed Web of Science ®Google Scholar
• Dippold W G, Lloyd K O, Li L TC, et al. Cell surface antigens of human malignant melanoma: Definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA 1980; 77: 6114–8
   PubMed Web of Science ®Google Scholar
• Wilson B S, Kay N E, Imai K, Ferrone S. Heterogeneity of human melanoma-associated antigens defined by monoclonal antibodies and conventional xenoantisera. Cancer Immunol Immunother 1982; 13: 69–74
   PubMed Web of Science ®Google Scholar
• Saxton R E, Mann B D, Morton D L, Burk M. W. Monoclonal antibodies to 125 kD and 95 kD proteins on human melanoma cells: Comparison with other monoclonal defined melanoma antigens. Hybridoma 1982; 1: 433–45
   Google Scholar
• Natali P G, Wilson B S, Imai K, et al. Tissue distribution, molecular profile and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells. Cancer Res 1982; 42: 583–9
   Google Scholar
• Galloway D R, McCabe R P, Pellegrino M A, et al. Tumor associated antigens in the spent media of human melanoma cells: Immunochemical characterization with xenoantisera. J Immunol 1981; 126: 62
   Google Scholar
• Morgan A C, Crane M M, Rossen R. D. Measurement of a monoclonal antibody-defined melanoma-associated antigen in human sera: Correlation of circulating antigen levels with tumor burden. J Natl Cancer Inst 1984; 72: 243–9
   Google Scholar
• Bumol T F, Chee D O, Reisfeld R. A. Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigen. Hybridoma 1982; 1: 283–92
   Google Scholar
• Carrel S, Schmidt-Kessen A, Mach J P, et al. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines. J Immunol 1983; 130: 2456–60
   Google Scholar
• Albino P A, Lloyd K O, Ikeda H, Old L. J. Biochemical analysis of a 130000 molecular weight glycoprotein on human melanoma cells. J Immunol 1983; 131: 1595–9
   PubMedGoogle Scholar
• Loop S M, Nishiyama K, Hellstrom I, et al. Two human tumor-associated antigens p155 and p210, detected by monoclonal antibodies. Int J Cancer 1981; 27: 775–81
   Google Scholar
• Imai K, Natali P G, Kay N E, et al. Tissue distribution and molecular profile of a differentiation antigen detected by a monoclonal antibody (345.134S) produced against human melanoma cells. Cancer Immunol Immunotherap 1982; 12: 159–66
   Google Scholar
• Khan A, Grammer S, Chang D, et al. Mouse monoclonal antibody (W1-MN-1) against malignant melanoma. Cancer Res 1983; 43: 5868–72
   Google Scholar
• Holzmann B, Johnson J P, Kaudewitz P, Reithmuller G. In situ analysis of antigens on malignant and benign cells of the melanocyte lineage: Differential expression of two surface molecules. gp75, p89, Submitted
   Google Scholar
• Herlyn M, Herlyn D, Elder D E, et al. Phenotypic characteristics of cells derived from precursors of human melanoma. Cancer Res 1983; 43: 5502–8
   Google Scholar
• Yan Pak K, Blaszczyk M, Steplewski Z, Koprowski H. Identification and isolation of a common tumor-associated molecule using monoclonal antibody. Mol Imunol 1983; 20: 1369–77
   Google Scholar
• Hageman P L, Vennegoor C, Van der Valk M, . Reactions of monoclonal antibodies against human melanoma with different tissues and cell lines. Protides of the biological fluids, H Peeters, et al. Pergamon Press, Oxford 1982; 889–2
   Google Scholar
• Van Duinen S G, Ruiter D J, Hageman P L, et al. Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma. Cancer 1984; 53: 1566–73
   PubMed Web of Science ®Google Scholar
• Mackie R M, Campbell I, Turbitt M. L. Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol 1984; 37: 367–72
   PubMed Web of Science ®Google Scholar
• Cochran A J, Wen D R, Herschman H R, Gaynor R. B. Detection of S-100 protein as an aid to the identification of melanocytic tumors. Int J Cancer 1982; 30: 295–7
   PubMed Web of Science ®Google Scholar
• Springall D R, Gu J, Cocchia D, et al. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. Virchows Arch Pathol Anat 1983; 400: 331–43
   Google Scholar
• Bruggen J, Sorg C. Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies. Cancer Immunol Immunother 1983; 15: 200–5
   Google Scholar
• Cobbold S P, Waldmann H. Therapeutic potential of monovalent monoclonal antibodies. Nature 1984; 308: 460–2
   Google Scholar
• Koprowski H, Herlyn D, Lubeck M, et al. Human antiidiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient. Proc Natl Acad Sci 1984; 81: 216–9
   PubMed Web of Science ®Google Scholar
• Capone P M, Papsidero L D, Chu T. M. Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors. J Natl Cancer Inst 1984; 72: 673–7
   PubMedGoogle Scholar
• Alam F, Soloway A H, Barth R F, et al. Proceedings of First International Symposium on Neutron Capture Therapy, In press
   Google Scholar
• Halpern S E, Hagan D L, Garver P R, et al. Stability, characterization and kinetics of 111In-labelled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. Cancer Res. 1983; 43: 5347–55
   PubMed Web of Science ®Google Scholar
• Weinstein J N, Steller M A, Keenan A M, et al. Monoclonal antibodies in the lymphatics: Selective delivery to lymph node metastases of a solid tumor. Science 1983; 222: 423–6
   PubMed Web of Science ®Google Scholar
• Atkinson B, Ernst C S, Ghrist B FD, et al. Identification of melanoma-associated antigens using fixed tissue screening of antibodies. Cancer Res 1984; 44: 2577–81
   PubMed Web of Science ®Google Scholar
• Brocker E B, Suter L, Sorg C. HLA-Dr antigen expression in primary melanomas of the skin. J Invest Dermatol 1984; 82: 244–7
   PubMed Web of Science ®Google Scholar